Evaluation of Leishmania donovani Protein Disulfide Isomerase as a Potential Immunogenic Protein/Vaccine Candidate against Visceral Leishmaniasis

Immunization with the DNA-Encoding N-Terminal Domain of Proteophosphoglycan of Leishmania donovani Generates Th1-Type Immunoprotective Response against Experimental Visceral Leishmaniasis

(2009) M. Samant et al.   JOURNAL OF IMMUNOLOGY

Proteomic approaches for discovery of new targets for vaccine and therapeutics against visceral leishmaniasis

(2008) Shraddha Kumari et al.   Proteomics Clinical Applications

Induction of Th1-type cellular responses in cured/exposed Leishmania-infected patients and hamsters against polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1kDa

(2008) Shraddha Kumari et al.   VACCINE

Cysteine proteinase type III is protective against Leishmania infantum infection in BALB/c mice and highly antigenic in visceral leishmaniasis individuals

(2008) Naghmeh Khoshgoo et al.   VACCINE

Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein

(2008) Ana Paula Fernandes et al.   VACCINE

Pathogenic role of B cells and antibodies in murine Leishmania amazonensis infection

(2007) Nanchaya Wanasen et al.   INTERNATIONAL JOURNAL FOR PARASITOLOGY